Insights

Strong Industry Position Vector Oncology is a recognized leader in oncology research and data analytics, with a highly experienced team and proprietary platforms like the Patient Care Monitor (PCM), creating opportunities to expand partnerships with pharmaceutical firms seeking high-quality real-world evidence.

Strategic Acquisitions Having been acquired by SymphonyAI and engaging in collaborations with entities like PrecisionHealth and CancerLinQ, Vector Oncology demonstrates a growth-oriented approach, opening avenues for joint ventures or enhanced service offerings in AI-driven healthcare solutions.

Market Revenue Scale With a revenue range between $100 million and $1 billion, the company presents a substantial market presence, indicating potential for high-value contracts and customized research services tailored to large biopharmaceutical and healthcare companies.

Clinical Trial Expertise Vector's role as a CRO for innovative cancer therapies like Actinium’s Actimab-A Phase 2 trial positions it as a prime partner for organizations seeking specialized clinical research and outcomes data, ideal for expanding trial support services or data analytics offerings.

Technological Engagement Utilizing advanced tech stacks including data warehousing, patient engagement platforms, and AI partnerships, Vector Oncology emphasizes innovation, presenting opportunities to introduce complementary technologies that enhance research capabilities and patient outcome monitoring.

Similar companies to ACORN

ACORN Tech Stack

ACORN uses 8 technology products and services including Fusion Ads, WordPress, Twemoji, and more. Explore ACORN's tech stack below.

Fusion Ads
Advertising
WordPress
Content Management System
Twemoji
Font Scripts
Hammer.js
Javascript Libraries
Modernizr
Javascript Libraries
PHP
Programming Languages
Yoast SEO
Search Engines
prettyPhoto
Web Tools And Plugins

Media & News

ACORN's Email Address Formats

ACORN uses at least 1 format(s):

ACORN Email Formats	Example	Percentage
FLast@vectoroncology.com	JDoe@vectoroncology.com	49%
First.Last@vectoroncology.com	John.Doe@vectoroncology.com	1%
FLast@vectoroncology.com	JDoe@vectoroncology.com	49%
First.Last@vectoroncology.com	John.Doe@vectoroncology.com	1%

Frequently Asked Questions

Where is ACORN's headquarters located?

ACORN's main headquarters is located at 6555 Quince Suite 400 Memphis, Tennessee 38119 US. The company has employees across 2 continents, including North AmericaAsia.

What is ACORN's phone number?

You can contact ACORN's main corporate office by phone at

+1-901-435-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ACORN's stock symbol?

ACORN is a publicly traded company; the company's stock symbol is CAEEX.

What is ACORN's official website and social media links?

ACORN's official website is vectoroncology.com and has social profiles on LinkedIn.

What is ACORN's NAICS code?

ACORN's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does ACORN have currently?

As of September 2025, ACORN has approximately 51 employees across 2 continents, including North AmericaAsia. Key team members include Director, Contracts And Budgets: L. S.Director, Quality Assurance: P. P.Senior Director Information Technology: P. B.. Explore ACORN's employee directory with LeadIQ.

What industry does ACORN belong to?

ACORN operates in the Research Services industry.

What technology does ACORN use?

ACORN's tech stack includes Fusion AdsWordPressTwemojiHammer.jsModernizrPHPYoast SEOprettyPhoto.

What is ACORN's email format?

ACORN's email format typically follows the pattern of FLast@vectoroncology.com. Find more ACORN email formats with LeadIQ.

When was ACORN founded?

ACORN was founded in 2002.

ACORN

Research ServicesTennessee, United States51-200 Employees

Vector Oncology is a leader in the design and delivery of care based oncology research and data analytics.  Utilizing our comprehensive Oncology Data Warehouse and proprietary Patient Care Monitor (PCM) patient engagement and outcomes platform, our experienced project teams, medical experts and health economics and outcomes scientists design and deliver high-quality projects generating real world evidence and insight. With some of the most experienced medical, scientific, operational, and executive teams in late stage research, Vector Oncology is uniquely positioned to meet the demand to demonstrate product value in terms of economic impact, clinical effectiveness and tolerability, and patient reported outcomes (PRO).